Literature DB >> 2548761

Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury.

R Bolli1, M O Jeroudi, B S Patel, O I Aruoma, B Halliwell, E K Lai, P B McCay.   

Abstract

Recent evidence suggests that postischemic myocardial dysfunction ("stunning") may be mediated by oxygen free radicals, but the exact time window during which the critical radical-mediated damage develops remains unknown. Furthermore, the evidence for the oxyradical hypothesis is indirect and, therefore, inconclusive. Thus, the potent and cell-permeable antioxidant N-(2-mercaptopropionyl)-glycine (MPG) was administered as an intra-coronary infusion (8 mg/kg/hr) to three groups of open-chest dogs undergoing a 15-minute coronary occlusion followed by 4 hours of reperfusion. In group I (n = 8), the infusion of MPG was started 15 minutes before occlusion and ended 2 hours after reperfusion; in group II (n = 9), MPG was started 1 minute before reperfusion and ended 2 hours thereafter; in group III (n = 10), MPG was started 1 minute after reperfusion and ended 2 hours and 15 minutes thereafter. Control dogs (group IV) (n = 10) received vehicle. Recovery of contractile function (assessed as systolic wall thickening) was equivalent in groups I and II, and in both groups it was substantially greater than in controls (p less than 0.005 at 4 hours). In contrast, in group III recovery of function was indistinguishable from controls. To determine whether the protection afforded by MPG was due to inhibition of free radical reactions, myocardial production of free radicals was directly assessed by intracoronary infusion of the spin trap alpha-phenyl N-tert-butyl nitrone (PBN). In control dogs (group VII, n = 6), radical adducts of PBN were released in the coronary venous blood after reperfusion, with a burst occurring in the first 5 minutes. MPG given as in group II (group V, n = 5) markedly suppressed myocardial production of PBN adducts (delta = -98% over 3 hours, p less than 0.01 vs. controls); this effect was evident immediately after reperfusion. MPG given as in group III (group VI, n = 5) also suppressed PBN adduct production (delta = -83% over 3 hours, p less than 0.025 vs. controls), but this effect was delayed. Hence, the radicals important in myocardial stunning appear to be those generated immediately after reperfusion. In vitro studies demonstrated that MPG is an exceptionally powerful scavenger of .OH (rate constant = 8.1 x 10(9) M-1 sec-1 by pulse radiolysis) but has no significant effect on .O2- (rate constant less than 10(3) M-1 sec-1), H2O2 (rate constant = 1.6 M-1 sec-1), or non-.OH-initiated lipid peroxidation, suggesting that removal of .OH is the major mechanism of the beneficial effects of MPG.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548761     DOI: 10.1161/01.res.65.3.607

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  94 in total

1.  Histological changes in the hearts of non-survivors of the UK collaborative trial of neonatal ECMO (extra corporeal membrane oxygen).

Authors:  M J Evans; J W Keeling
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

2.  Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

3.  Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids.

Authors:  Karin Wetzelberger; Shahid P Baba; Mahesh Thirunavukkarasu; Ye-Shih Ho; Nilanjana Maulik; Oleg A Barski; Daniel J Conklin; Aruni Bhatnagar
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 4.  Mechanism of cardioprotection by early ischemic preconditioning.

Authors:  Xiulan Yang; Michael V Cohen; James M Downey
Journal:  Cardiovasc Drugs Ther       Date:  2010-06       Impact factor: 3.727

5.  Reperfusion Injury: Basic Concepts and Protection Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

6.  Pathobiology and Clinical Impact of Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 7.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

8.  Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator.

Authors:  Yanping Liu; Xi-Ming Yang; Efstathios K Iliodromitis; Dimitrios T Kremastinos; Turhan Dost; Michael V Cohen; James M Downey
Journal:  Basic Res Cardiol       Date:  2007-11-12       Impact factor: 17.165

9.  Microdialysis study of ischemia-induced hydroxyl radicals in the canine heart.

Authors:  A A Timoshin; O V Tskitishvili; L I Serebryakova; A I Kuzmin; O S Medvedev; E K Ruuge
Journal:  Experientia       Date:  1994-07-15

10.  Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C.

Authors:  Atsushi Kuno; Nataliya V Solenkova; Victoriya Solodushko; Turhan Dost; Yanping Liu; Xi-Ming Yang; Michael V Cohen; James M Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.